Case study
MaxCyte helped a partner refine their T cell therapy process
Intro
In this video, Senior Field Application Scientist, Alicia Roig-Merino, PhD shows how MaxCyte helped a partner refine their T cell therapy process—from culture conditions and mRNA design to electroporation—resulting in over 90% viability. Through hands-on troubleshooting and training, MaxCyte supported the customer at every step, ensuring faster progress to the clinic and exemplifying a collaborative approach that goes beyond standard equipment support.
Related Resources
Learn how MaxCyte's field applications scientists accelerate preclinical development for our cell therapy partners, ensuring that life-saving therapies reach patients when needed.
Why Partner with MaxCyte
Our partnership model is designed to guide you seamlessly through each phase from discovery to commercialization, offering scalable solutions, regulatory expertise, and operational support tailored to your needs.
